These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31027208)

  • 1. Mast Cells in Early Rheumatoid Arthritis.
    Rivellese F; Rossi FW; Galdiero MR; Pitzalis C; de Paulis A
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mast cell subsets--distinct functions in inflammation?
    McNeil HP; Gotis-Graham I
    Inflamm Res; 2000 Jan; 49(1):3-7. PubMed ID: 10778914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
    Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
    Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of mast cells in human synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
    Fritz P; Müller J; Reiser H; Saal JG; Hadam M; Rautenstrauch H; Tuczek HV; Mischlinski A
    Z Rheumatol; 1984; 43(6):294-8. PubMed ID: 6084372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcγ receptor I and Fcγ receptor II.
    Lee H; Kashiwakura J; Matsuda A; Watanabe Y; Sakamoto-Sasaki T; Matsumoto K; Hashimoto N; Saito S; Ohmori K; Nagaoka M; Tokuhashi Y; Ra C; Okayama Y
    Arthritis Rheum; 2013 Jan; 65(1):109-19. PubMed ID: 23055095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis.
    Gotis-Graham I; Smith MD; Parker A; McNeil HP
    Ann Rheum Dis; 1998 Nov; 57(11):664-71. PubMed ID: 9924208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].
    Seemayer CA; Distler O; Kuchen S; Müller-Ladner U; Michel BA; Neidhart M; Gay RE; Gay S
    Z Rheumatol; 2001 Oct; 60(5):309-18. PubMed ID: 11759230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production.
    Rivellese F; Mauro D; Nerviani A; Pagani S; Fossati-Jimack L; Messemaker T; Kurreeman FAS; Toes REM; Ramming A; Rauber S; Schett G; Jones GW; Jones SA; Rossi FW; de Paulis A; Marone G; El Shikh MEM; Humby F; Pitzalis C
    Ann Rheum Dis; 2018 Dec; 77(12):1773-1781. PubMed ID: 30127058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
    Juurikivi A; Sandler C; Lindstedt KA; Kovanen PT; Juutilainen T; Leskinen MJ; Mäki T; Eklund KK
    Ann Rheum Dis; 2005 Aug; 64(8):1126-31. PubMed ID: 16014680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells in rheumatoid arthritis.
    Maruotti N; Crivellato E; Cantatore FP; Vacca A; Ribatti D
    Clin Rheumatol; 2007 Jan; 26(1):1-4. PubMed ID: 16741781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.
    Okamura Y; Mishima S; Kashiwakura JI; Sasaki-Sakamoto T; Toyoshima S; Kuroda K; Saito S; Tokuhashi Y; Okayama Y
    Allergol Int; 2017 Sep; 66S():S9-S20. PubMed ID: 28366675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy.
    Bridges AJ; Malone DG; Jicinsky J; Chen M; Ory P; Engber W; Graziano FM
    Arthritis Rheum; 1991 Sep; 34(9):1116-24. PubMed ID: 1930330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertiary Lymphoid Organs in Rheumatoid Arthritis.
    Rivellese F; Pontarini E; Pitzalis C
    Curr Top Microbiol Immunol; 2020; 426():119-141. PubMed ID: 32483659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between D3R expression in synovial mast cells and disease activity and oxidant status in patients with rheumatoid arthritis.
    Xue L; Li X; Chen Q; He J; Dong Y; Wang J; Shen S; Jia R; Zang QJ; Zhang T; Li M; Geng Y
    Clin Rheumatol; 2018 Oct; 37(10):2621-2632. PubMed ID: 29934747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells.
    Palmer HS; Kelso EB; Lockhart JC; Sommerhoff CP; Plevin R; Goh FG; Ferrell WR
    Arthritis Rheum; 2007 Nov; 56(11):3532-40. PubMed ID: 17968878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression.
    Gotis-Graham I; McNeil HP
    Arthritis Rheum; 1997 Mar; 40(3):479-89. PubMed ID: 9082936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhomogeneity of immune cell composition in the synovial sublining: linear mixed modelling indicates differences in distribution and spatial decline of CD68+ macrophages in osteoarthritis and rheumatoid arthritis.
    Mucke J; Hoyer A; Brinks R; Bleck E; Pauly T; Schneider M; Vordenbäumen S
    Arthritis Res Ther; 2016 Jul; 18():170. PubMed ID: 27424032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of synovial mast cells in knee osteoarthritis: association with clinical parameters.
    de Lange-Brokaar BJ; Kloppenburg M; Andersen SN; Dorjée AL; Yusuf E; Herb-van Toorn L; Kroon HM; Zuurmond AM; Stojanovic-Susulic V; Bloem JL; Nelissen RG; Toes RE; Ioan-Facsinay A
    Osteoarthritis Cartilage; 2016 Apr; 24(4):664-71. PubMed ID: 26671522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis progression mediated by activated synovial fibroblasts.
    Neumann E; Lefèvre S; Zimmermann B; Gay S; Müller-Ladner U
    Trends Mol Med; 2010 Oct; 16(10):458-68. PubMed ID: 20739221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.